These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30181834)

  • 21. Tonsillar Extraintestinal Enteropathy-Associated T-Cell Lymphoma in a Patient With Celiac Disease.
    Kronsten VT; Gosson C; Al-Khatib A; Bagwan I; Worthington T; Muthalali S; Ethell M; Lim G; Youd P
    ACG Case Rep J; 2022 Jul; 9(7):e00824. PubMed ID: 35811577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCD.
    van Wanrooij RL; de Jong D; Langerak AW; Ylstra B; van Essen HF; Heideman DA; Bontkes HJ; Mulder CJ; Bouma G
    BMJ Open Gastroenterol; 2015; 2(1):e000026. PubMed ID: 26462278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the role of celiac disease in enteropathy-type intestinal lymphoma? A retrospective study of nine cases.
    Van Overbeke L; Ectors N; Tack J
    Acta Gastroenterol Belg; 2005; 68(4):419-23. PubMed ID: 16432993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How I treat enteropathy-associated T-cell lymphoma.
    Di Sabatino A; Biagi F; Gobbi PG; Corazza GR
    Blood; 2012 Mar; 119(11):2458-68. PubMed ID: 22271451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
    Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
    Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.
    Wierdsma NJ; Nijeboer P; de van der Schueren MA; Berkenpas M; van Bodegraven AA; Mulder CJ
    Clin Nutr; 2016 Jun; 35(3):685-91. PubMed ID: 25979847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory celiac disease.
    Rishi AR; Rubio-Tapia A; Murray JA
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):537-46. PubMed ID: 26603931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell repertoires in refractory coeliac disease.
    Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
    Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cavitating mesenteric lymph node syndrome in association with coeliac disease and enteropathy associated T-cell lymphoma: a case report and review of the literature.
    McBride OM; Skipworth RJ; Leitch D; Yalamarthi S
    Case Rep Med; 2010; 2010():478269. PubMed ID: 21253476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced enteropathy-associated T cell lymphoma (EATL) presenting with severe malabsorption and concomitantly diagnosed coeliac disease (CD).
    Rajagopal A; Thompson CA; Chorzempa AK; Ryu AJ
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38142052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cavitating mesenteric lymph node syndrome: a rare complication of refractory celiac disease.
    Sanson E; Gassler N; Trautwein C; Wasmuth HE
    Z Gastroenterol; 2010 Sep; 48(9):1133-7. PubMed ID: 20839163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical staging and survival in refractory celiac disease: a single center experience.
    Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
    Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features.
    Margolskee E; Jobanputra V; Lewis SK; Alobeid B; Green PH; Bhagat G
    PLoS One; 2013; 8(7):e68343. PubMed ID: 23861889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of double-balloon enteroscopy in patients with refractory celiac disease.
    Hadithi M; Al-toma A; Oudejans J; van Bodegraven AA; Mulder CJ; Jacobs M
    Am J Gastroenterol; 2007 May; 102(5):987-96. PubMed ID: 17378908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enteropathy-associated T-cell lymphoma: a diagnostic challenge].
    Busto Bea V; Crespo Pérez L; Rodríguez-Gandía MÁ; Roy Ariño G; García-Miralles N; Cano Ruiz A
    Gastroenterol Hepatol; 2011 Dec; 34(10):686-9. PubMed ID: 22112633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory celiac disease: from bench to bedside.
    Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
    Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celiac disease: a clinical review.
    Al-Bawardy B; Codipilly DC; Rubio-Tapia A; Bruining DH; Hansel SL; Murray JA
    Abdom Radiol (NY); 2017 Feb; 42(2):351-360. PubMed ID: 28078381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of coeliac disease.
    Malamut G; Cellier C
    Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased circulating iNKT cell numbers in refractory coeliac disease.
    Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
    Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approach to patients with refractory coeliac disease.
    Nasr I; Nasr I; Campling H; Ciclitira PJ
    F1000Res; 2016; 5():. PubMed ID: 27803799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.